B Ndiaye

Safety, immunogenicity, and efficacy of the candidate tuberculosis vaccine MVA85A in healthy adults infected with HIV-1: a randomised, placebo-controlled, phase 2 trial

B Ndiaye, Friedrich Thienemann, Martin O. C. Ota et al. · The Lancet Respiratory Medicine · 2015 · 163 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Safety and Immunogenicity of a Heterologous Prime-Boost Ebola Virus Vaccine Regimen in Healthy Adults in the United Kingdom and Senegal

Navin Venkatraman, B Ndiaye, Georgina Bowyer et al. · The Journal of Infectious Diseases · 2018 · 83 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in adults in Africa: a randomised, observer-blind, placebo-controlled, phase 2 trial

Milagritos D. Tapia, Samba O. Sow, B Ndiaye et al. · The Lancet Infectious Diseases · 2020 · 76 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14

Multisite Evaluation of a Point-of-Care Instrument for CD4+ T-Cell Enumeration Using Venous and Finger-Prick Blood

Papa Alassane Diaw, Géraldine Daneau, Abdoul Aziz Coly et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2011 · 72 citations

Public Health, Immunology, Hiv Control +14

Vaccination coverage and immunization timeliness among children aged 12-23 months in Senegal: a Kaplan-Meier and Cox regression analysis approach

Mouhamed Abdou Salam, Aminata Mboup, Indou Déme Ly et al. · Pan African Medical Journal · 2017 · 65 citations · Full text

Public Health, Child Health, Pediatrics +17